Zhejiang Huahai Pharmaceutical Co., Ltd.
600521
Classement en actions
#4252
Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical... Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical enterprise with a global presence. Its diverse portfolio encompasses treatments for central nervous system disorders, cardiovascular conditions, and viral infections, among other finished pharmaceutical products. Beyond finished drugs, the company also produces Active Pharmaceutical Ingredients (APIs) and crucial intermediates. Huahai Pharmaceutical further engages in the manufacturing of packaging components, notably high-density polyethylene (HDPE) bottles and polypropylene (PP) caps. Additionally, it offers contract manufacturing (CMO) and other specialized services, while also playing a role in import and export trade services. Established in 1989, the company maintains its headquarters in Linhai, China.
Prix de l'action
$2.49
Dernière synchronisation: 2026-10-21
Capitalisation boursière
$3.73B
Changement (1 jour)
2.72%
Changement (1 an)
-6.10%
Pays
CN
Échange Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)
Catégorie
Healthcare
Revenus pour Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)
Revenus en Jun 2026 TTM : $1.30B
Selon les derniers rapports financiers de Zhejiang Huahai Pharmaceutical Co., Ltd., le chiffre d'affaires actuel de l'entreprise (TTM) est de $1.30B. En 2023, l'entreprise a réalisé un chiffre d'affaires de $1.17B une diminution par rapport à le chiffre d'affaires de l'année 2022, qui était de $1.20B. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Zhejiang Huahai Pharmaceutical Co., Ltd. de 2000 à 2026
Revenus à la fin de chaque année
| Année | Revenus | Changez |
|---|---|---|
| 2026 (TTM) | $1.30B | -0.47% |
| 2024 | $1.31B | 11.44% |
| 2023 | $1.17B | -2.05% |
| 2022 | $1.20B | 14.64% |
| 2021 | $1.05B | 5.29% |
| 2020 | $992.73M | 28.30% |
| 2019 | $773.78M | 4.47% |
| 2018 | $740.64M | -3.66% |
| 2017 | $768.81M | 30.42% |
| 2016 | $589.50M | 9.36% |
| 2015 | $539.03M | 29.16% |
| 2014 | $417.34M | 10.24% |
| 2013 | $378.58M | 17.20% |
| 2012 | $323.04M | 13.48% |
| 2011 | $284.66M | 83.69% |
| 2010 | $154.97M | 14.01% |
| 2009 | $135.92M | 15.73% |
| 2008 | $117.45M | 21.30% |
| 2007 | $96.82M | 34.94% |
| 2006 | $71.75M | 36.84% |
| 2005 | $52.43M | 10.94% |
| 2004 | $47.26M | 29.07% |
| 2003 | $36.62M | 61.75% |
| 2002 | $22.64M | 5.36% |
| 2001 | $21.49M | 30.66% |
| 2000 | $16.45M | 0.00% |
Revenus d’entreprises similaires ou concurrentes
| Entreprise | Revenus | Différence de revenus | Pays |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 407.87% |
IN
|
